Therefore, our findings suggest that targeting the TFPI2/CLIP1/TIRAP signaling pathway with HOPE could be a potential therapeutic strategy for alleviated IRI in fatty liver transplantation. The gene discussed is TFPI2; the disease is fatty liver disease.